Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map

Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map

Abstract Background Patients with chronic kidney disease (CKD) require a personalised strategy for cardiovascular risk management (CVRM) to reduce their high risk of cardiovascular morbidity and mortality. Despite their high risk, patients with CKD appear to be underrepresented in randomised control...

Full description

Bibliographic Details
Main Authors: Julia M. T. Colombijn, Demy L. Idema, Kim van der Braak, Rene Spijker, Sabine C. A. Meijvis, Michiel L. Bots, Lotty Hooft, Marianne C. Verhaar, Robin W. M. Vernooij
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Systematic Reviews
Subjects:
Chronic kidney disease
Cardiovascular disease
Cardiovascular risk management
Evidence map
Online Access:https://doi.org/10.1186/s13643-022-02108-x

Internet

https://doi.org/10.1186/s13643-022-02108-x

Similar Items